MAP2K7 and colorectal carcinoma: We also observed an activation of CRAF after the MEKi treatment in the CRC cells, suggesting that CRAF may be the key molecule that mediates the feedback inhibition of the RAS-RAF-MEK-ERK signaling pathway.